Antigen-Antibody ComplexBlood PlateletsCrohn Disease
Dr. Michael A. Kosmo, MD
NPI1891742847
- Medicare services, 2023
- 7,930
- Part D claims, 2023
- 199
- Publications
- 2
- Clinical trials
- 9
- Industry payments
- $16,090
- Practice address
- 838 Nordahl Rd Suite 300 Suite 300, San Marcos, CA 92069-3599
- Practice phone
- Call (760) 747-8935
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Ccare
Multi-specialty group site · San Marcos, California
Find Dr. Kosmo's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Michael A. Kosmo is a hematologist and oncologist in Escondido, California
Dr. Kosmo practices at Ccare in San Marcos, California.
Dr. Kosmo's NPI, 1891742847, was assigned on May 27, 2006. Dr. Kosmo graduated from UMass Chan Medical School in 1979. Dr. Kosmo holds California license G54074.
NPI and contact details
- NPI
- 1891742847NPI Registry (opens in a new tab)
- NPI enumeration date
- May 27, 2006
- NPI status
- Active
- Practice phone
- (760) 747-8935
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 73
- Medical school graduation
- 1979
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Michael A. Kosmo practices in San Marcos and Escondido
Dr. Kosmo's primary practice is Ccare, at 838 Nordahl Rd Suite 300 Suite 300, San Marcos, CA 92069-3599. The practice phone is (760) 747-8935. The NPI Registry lists Dr. Kosmo's practice address as 2185 Citracado Pkwy, Escondido, CA 92029.
- CcarePrimary838 Nordahl Rd Suite 300 Suite 300, San Marcos, CA 92069-3599Phone(760) 747-8935
- NPI Registry address2185 Citracado Pkwy, Escondido, CA 92029 · San Diego CountyPhone(760) 747-8935
Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; Doctors and Clinicians National Downloadable File (CMS); and Dmand AI Practice Data
Dr. Michael A. Kosmo is affiliated with 1 site of care and 1 medical group
Dr. Kosmo's primary practice is Ccare in San Marcos, California. The medical group on file is California Cancer Associates for Research and Excellence (cCARE).
Sources: Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dmand AI tracks the EHR system at Dr. Michael A. Kosmo's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kosmo practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Ccare | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Kosmo practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Michael A. Kosmo is one of 1,502 hematologists and oncologists in California
Hematology and oncology is Dr. Kosmo's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kosmo is board certified in hematology by the American Board of Internal Medicine. Dr. Kosmo is licensed in California.
Specialties and state licenses
- Hematology and oncology, CaliforniaPrimary
Clinical focus
Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Kosmo treats.
Hematologists and oncologists near Dr. Kosmo
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
1,502hematologists and oncologists in California
3hematologists and oncologists in Escondido
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Michael A. Kosmo billed Medicare for 7,930 services in 2023
CMS data shows 7,930 Medicare services from Dr. Kosmo across 16 procedure codes in 2023. Medicare paid $58,627 for them. Every service was in an office.
Medicare services, 20237,930
Paid by Medicare$58,627
Procedure codes16
Dr. Kosmo's Medicare services by type, 2022 to 2023
- 2022
- 2023
- Drugs given in the office
- 2022: 88,4512023: 7,00092%
- Lab and pathology
- 2022: 2,2282023: 54076%
- Surgery
- 2022: 6442023: 23464%
- Office and hospital visits
- 2022: 1,1722023: 8493%
- Tests and treatments
- 2022: 7322023: 3695%
- Other services
- 2022: 2,8492023: 1999%
- Imaging
- 2022: 952023: 1782%
Dr. Kosmo compared with the California median for hematologists and oncologists, 2023
- Dr. Kosmo
- California median
- Medicare services
- 7,930vs 9328.5 times
- Part D claims
- 199vs 39449% below
Medians across 1,367 hematologists and oncologists in California with Dmand AI profiles that report each measure.
Dr. Kosmo's most billed Medicare procedure codes, 2023
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Kosmo?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kosmo and other hematologists and oncologists in California.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Michael A. Kosmo's patients have a median age of 69
Across all payers, Dmand AI patient panel data puts Dr. Kosmo's median patient age at 69, with 55% women.
Dr. Kosmo's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 69
Patient panel by sex, all payers
- Women55%
- Men45%
Source: Dmand AI Patient Panel Data
Dr. Michael A. Kosmo wrote 199 Medicare Part D claims in 2023
In 2023, Dr. Kosmo wrote 199 Medicare Part D claims. Every claim was for a generic drug. They cover 9 drugs, with $297,727 in total drug cost. In 2022, CMS named 637 claims across 21 drugs.
Part D claims, 2023199
Drugs named by CMS9
Total drug cost$297,727
Dr. Kosmo's most prescribed drugs by claims, 2023
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2022 to 2023
- 2022
- 2023
- Claims for drugs CMS names
- 2022: 6372023: 19969%
Drugs named by CMS: 9 in 2023, 21 in 2022.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Kosmo by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Michael A. Kosmo has 2 publications on record
Dmand AI links 2 papers to Dr. Kosmo.
Papers2
Recent publications by Dr. Kosmo
See who Dr. Kosmo researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kosmo works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Michael A. Kosmo has worked on 9 clinical trials
Dmand AI links Dr. Kosmo to 9 clinical trials, 2 of them phase 1 studies. 4 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Agranulocytosis. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Kosmo that name 4 trials.
Clinical trials with Dr. Kosmo by phase
- 2Phase 1: 2 trials
- 2Phase 2: 2 trials
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Kosmo's trials
- Breast Neoplasms
- Breast Diseases
- Agranulocytosis
- Carcinoma, Non-Small-Cell Lung
- Leukemia, Lymphocytic, Chronic, B-Cell
Investigators on the most trials with Dr. Kosmo
- Sucharu Prakash, MD4 shared trials
- Nicholette L. Erickson, MD3 shared trials
- Bobby L. Graham, MD3 shared trials
Recent clinical trials with Dr. Kosmo
Triple Negative Breast NeoplasmsRectal NeoplasmsFruquintinib (HMPL-013)
Tomivosertib Combined With Pembrolizumab in Subjects With PD-L1 Positive NSCLC (KICKSTART) (opens in a new tab)
Active, not recruitingPhase 2
Carcinoma, Non-Small-Cell LungCarcinoma, BronchogenicPembrolizumabTomivosertibPemetrexed
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC (opens in a new tab)
TerminatedPhase 3
Neoplasm MetastasisNeoplastic ProcessesCapecitabineTesetaxel and Capecitabine
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients (opens in a new tab)
RecruitingPhase 1
Multiple MyelomaBlood Protein DisordersLenalidomideMethylprednisoloneRuxolitinib Oral Tablet [Jakafi]
Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer (opens in a new tab)
CompletedPhase 2
AgranulocytosisNeutropeniaPegfilgrastimSPI-2012Cyclophosphamide
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Michael A. Kosmo received $16,090 in industry payments from 2016 to 2025
CMS Open Payments shows 888 general payments to Dr. Kosmo from 76 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Merck Sharp & Dohme Corporation paid the most, $1,516. It also lists 12 research payments totaling $29,713 from 2016 to 2023, naming 4 clinical trials.
General payments to Dr. Kosmo by program year, 2016 to 2025
General payments to Dr. Kosmo by kind, 2016 to 2025
$16.1Kin total
- Food and beverage$15,64897%
- Education$4413%
Companies that paid Dr. Kosmo the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Michael A. Kosmo graduated from UMass Chan Medical School
Dr. Kosmo graduated from UMass Chan Medical School in 1979.
- Medical school
- Board certified in hematology
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Michael A. Kosmo accepts plans from 6 insurance carriers
Dr. Kosmo is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Elevance and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.
- Blue Cross Blue Shield of Michigan
- Elevance
- HCSC
- Molina
- Regence Health Plans
- Humana
Plan types Dr. Kosmo accepts, by number of carriers
- Medicare5
- PPO4
- HMO3
- POS2
Source: Dmand AI Insurance Network Data
Sources for Dr. Michael A. Kosmo's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Michael A. Kosmo
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Michael A. Kosmo's NPI number?
Dr. Michael A. Kosmo's NPI number is 1891742847. It was assigned on May 27, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Michael A. Kosmo?
Dr. Michael A. Kosmo is a hematologist and oncologist in Escondido, California. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Michael A. Kosmo practice?
Dr. Kosmo practices at 838 Nordahl Rd Suite 300 Suite 300, San Marcos, CA 92069-3599. Dr. Kosmo also practices at 2185 Citracado Pkwy, Escondido, CA 92029. Dr. Kosmo's primary practice is Ccare in San Marcos, California.
What is Dr. Michael A. Kosmo's office phone number?
The practice phone on file for Dr. Kosmo is (760) 747-8935.
What is Dr. Michael A. Kosmo's medical license number?
Dr. Kosmo holds California license G54074.
What medical group is Dr. Michael A. Kosmo part of?
Dr. Kosmo is linked to California Cancer Associates for Research and Excellence (cCARE).
Does Dr. Michael A. Kosmo accept Medicare?
Yes. CMS data shows Dr. Kosmo billed Medicare for 7,930 services in 2023.
Is Dr. Michael A. Kosmo board certified?
Yes. Dr. Kosmo is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. Michael A. Kosmo bill to Medicare?
In 2023, Dr. Kosmo's most billed Medicare services were injected or infused drug (J0881), surgery: heart and blood vessels (36415) and lab and pathology test (85025).
Where did Dr. Michael A. Kosmo go to medical school?
Dr. Kosmo graduated from UMass Chan Medical School in 1979.
Show 5 more questionsShow fewer questions
What drugs does Dr. Michael A. Kosmo prescribe most?
In 2023 Medicare Part D data, Dr. Kosmo's most prescribed drugs by claims were Anastrozole, Hydroxyurea and Dexamethasone.
Has Dr. Michael A. Kosmo received payments from drug or device companies?
CMS Open Payments shows $16,090 in general payments to Dr. Kosmo from 76 companies from 2016 to 2025. The largest total came from Merck Sharp & Dohme Corporation.
How long has Dr. Michael A. Kosmo been practicing?
Dr. Kosmo graduated from medical school in 1979, 47 years ago.
Does Dr. Michael A. Kosmo do research?
Dmand AI links 2 publications to Dr. Kosmo. Dr. Kosmo has worked on 9 clinical trials.
What insurance does Dr. Michael A. Kosmo accept?
Dr. Kosmo is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Elevance and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card